Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: New Perspectives in Diabetes Mellitus

Diagnosis Modalities

Michelle Renee Campbell and Masih Shokrani
American Society for Clinical Laboratory Science April 2016, 29 (2) 111-113; DOI: https://doi.org/10.29074/ascls.29.2.111
Michelle Renee Campbell
Medical Laboratory Sciences Program, Northern Illinois University, DeKalb, IL
MLS (ASCP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masih Shokrani
Medical Laboratory Sciences Program, Northern Illinois University, DeKalb, IL
Ph.D. MT (ASCP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mshokrani@niu.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Michelle Renee Campbell, MLS (ASCP)
    1. Medical Laboratory Sciences Program, Northern Illinois University, DeKalb, IL
  2. Masih Shokrani, Ph.D. MT (ASCP)⇑
    1. Medical Laboratory Sciences Program, Northern Illinois University, DeKalb, IL
  1. Address for Correspondence: Masih Shokrani, Ph.D. MT (ASCP), Associate Professor, Medical Laboratory Sciences Program, Northern Illinois University, DeKalb, IL, 60115-2828, 815-753-6323, mshokrani{at}niu.edu
  1. Discuss the use of fasting blood glucose, HbA1c and oral glucose tolerance testing for screening and diagnosis of diabetes mellitus.

  2. Differentiate screening procedures for type 1 and type 2 diabetes mellitus.

  3. Describe testing for gestational diabetes.

  4. Identify various autoantibodies and their association with type 1 diabetes mellitus.

Extract

INTRODUCTION Proper testing for both type 1 and 2 diabetes mellitus is vital in the diagnostic process, monitoring the progression of the disease and determining the efficacy of treatment. According to the American Diabetes Association (ADA), in the absence of indisputable hyperglycemia, the diagnosis of diabetes mellitus should always be confirmed with repeat testing.1 Timing of testing, as well as the specific tests ordered, may vary. The same basic tests, however, are utilized across most facilities.2 Fasting plasma glucose, hemoglobin A1c (HbA1c) and oral glucose tolerance testing (OGTT) are all recommended for both screening and diagnosis of diabetes mellitus.2

Various Testing Procedures The test often used to detect diabetes mellitus is a measurement of fasting blood glucose levels. After the patient has fasted overnight (at least 8 hours), blood sugar levels are measured using a methodology similar to that for random blood sugar levels. Fasting blood sugar levels of less than 100 mg/dL (~5.5 mmol/L) are normal. Levels between 100 and 125 mg/dL (~5.5-6.9 mmol/L) are considered prediabetic; levels above 125 mg/dL (~6.9 mmol/L) are considered diabetic in nature. Results hinge on the patient's compliance with fasting instructions prior to testing.3

HbA1c levels need to be measured as well. HbA1c is measured in percentages and reflects the average blood glucose levels over the past 3 months. HbA1c may be measured at any time, regardless of the last meal ingested.4 An International Expert Committee and the American Diabetes Association have declared hemoglobin A1c measurements accurate enough to be used for the…

ABBREVIATIONS: HbA1c - Hemoglobin A1c, ADA - American Diabetes Association, OGTT - Oral glucose tolerance test, G6P - Glucose-6-phosphate ICA - Islet cell antibody, GADA - Glutamic acid decarboxylase antibody, IA-2A - Islet antigen-2 antibody, IAA- Insulin autoantibody

    INDEX TERMS
  • Fasting Blood Glucose
  • HbA1c
  • Oral Glucose Tolerance Test
  • Screening for Type 1 Diabetes Mellitus
  • Gestational Diabetes Testing
  1. Discuss the use of fasting blood glucose, HbA1c and oral glucose tolerance testing for screening and diagnosis of diabetes mellitus.

  2. Differentiate screening procedures for type 1 and type 2 diabetes mellitus.

  3. Describe testing for gestational diabetes.

  4. Identify various autoantibodies and their association with type 1 diabetes mellitus.

  • © Copyright 2016 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 29 (2)
American Society for Clinical Laboratory Science
Vol. 29, Issue 2
Spring 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnosis Modalities
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diagnosis Modalities
Michelle Renee Campbell, Masih Shokrani
American Society for Clinical Laboratory Science Apr 2016, 29 (2) 111-113; DOI: 10.29074/ascls.29.2.111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Diagnosis Modalities
Michelle Renee Campbell, Masih Shokrani
American Society for Clinical Laboratory Science Apr 2016, 29 (2) 111-113; DOI: 10.29074/ascls.29.2.111
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Introduction, Background and Various Types
  • Diabetes Management and Future Trends
Show more Focus: New Perspectives in Diabetes Mellitus

Similar Articles

Keywords

  • Fasting Blood Glucose
  • HbA1c
  • Oral Glucose Tolerance Test
  • Screening for Type 1 Diabetes Mellitus
  • Gestational Diabetes Testing

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire